- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04834193
Wet-suction Versus Slow-pull for EUS-FNB of Solid Lesions (WEST-FNB)
March 19, 2022 updated by: Stefano Francesco Crinò, MD, Azienda Ospedaliera Universitaria Integrata Verona
Wet-suction Versus Slow-pull Technique for Endoscopic Ultrasound-guided Fine-needle Biopsy of Solid Lesions: a Multicentric Randomized Controlled Trial
A randomized cross-over study investigating the impact of two different suction techniques on histological yield and sample quality of specimens collected by endoscopic ultrasound biopsy from solid lesions using histology needles.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Verona, Italy, 37134
- Azienda Ospedaliera Integrata Verona
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Solid pancreatic lesions 3 1cm
- Peri-GI tract lymph nodes 3 1cm
- Peri-GI tract masses
- Lesions of the GI wall
- Signed informed consent
Exclusion Criteria:
- Pancreatic cystic lesions (more than 50% of the volume)
- Diameter of lesion ≤ 1 cm
- Lesion not seen at EUS
- Pregnancy
- Coagulopathy (platelet count <50.000/mm3 and/or international normalized ratio >1.5);
- Severe cardiorespiratory dysfunction precluding endoscopy;
- Failure to provide informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: WET-SUCTION
The stylet will be removed and the needle will be pre-flushed with 1-2mL of saline.
The lesion will then be punctured, and suction will be applied using a 10-mL pre-vacuum syringe.
The sample collected will be pushed into a formalin vial with saline.
|
Solid lesions will be sampled under endoscopic ultrasound guidance using the two techniques (wet-suction and slow-pull)
|
|
Active Comparator: SLOW-PULL
After puncturing the lesion, the stylet will be slowly and gradually withdrawn for at least 40cm.
The sample will be pushed into formalin using the stylet.
|
Solid lesions will be sampled under endoscopic ultrasound guidance using the two techniques (wet-suction and slow-pull)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Histologic yield
Time Frame: 6 months
|
The rate of samples containing a tissue "core" (yes/no) for histological evaluation, defined as an intact piece of tissue of at least 550 μ
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tissue integrity
Time Frame: 6 months
|
Tissue integrity will be evaluated by attributing a score from zero to 3 (3 represents the better outcome), according to the following score system: 0: No cells/tissue
|
6 months
|
|
Blood contamination
Time Frame: 6 months
|
Blood contamination will be evaluated by attributing a score from zero to 3 (3 represents the better outcome), according to the following score system: 0: Only blood
|
6 months
|
|
Tumor fraction
Time Frame: 6 months
|
The rate of samples containing an adequate tumor fraction ≥20 percent (i.e., ≥ 20 percent tumor cells in a background of benign nucleated cells).
|
6 months
|
|
Diagnostic accuracy
Time Frame: 6 months
|
Diagnostic accuracy (defined as the ratio between the sum of true positive and true negative values divided by the number of lesions) will be calculated for each study arm
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 29, 2021
Primary Completion (Actual)
October 30, 2021
Study Completion (Anticipated)
April 30, 2022
Study Registration Dates
First Submitted
March 29, 2021
First Submitted That Met QC Criteria
April 5, 2021
First Posted (Actual)
April 8, 2021
Study Record Updates
Last Update Posted (Actual)
March 22, 2022
Last Update Submitted That Met QC Criteria
March 19, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 18/22.09.2020
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endoscopic Ultrasound
-
Mayo ClinicFisher and Paykel HealthcareEnrolling by invitationEndoscopic UltrasoundUnited States
-
Renmin Hospital of Wuhan UniversityNot yet recruitingEndoscopic UltrasoundChina
-
Indiana UniversityVyaire MedicalTerminatedEndoscopic UltrasoundUnited States
-
University of California, IrvineCompletedEndoscopic Retrograde Cholangiopancreatography (ERCP) | Endoscopic Ultrasound (EUS)United States
-
Chinese University of Hong KongCompletedPatients Undergoing Endoscopic UltrasoundHong Kong
-
Qilu Hospital of Shandong UniversityThe Affiliated Hospital of Qingdao University; Shandong Provincial Hospital; Qianfoshan... and other collaboratorsRecruitingEndoscopic Ultrasound (EUS) | Solid Pancreatic LesionChina
-
Ramsay Générale de SantéEuropean Clinical Trial Experts NetworkCompletedEndoscopic Retrograde Cholangiopancreatography | Biliary Drainage | Echography UltrasoundFrance
-
Kasr El Aini HospitalCompletedUltrasound | Gastric | Transanal Endoscopic Surgical Procedures | Residual VolumeEgypt
-
Sohag UniversityRecruitingEfficacy of Endoscopic Ultrasound Guided Liver Biopsy Using Dynamic Wet TechniqueEgypt
-
Second Affiliated Hospital, School of Medicine,...CompletedFundal Gastric Varices | Endoscopic Ultrasound (EUS)-Guided Coil Deployment | Titanium Clips | Ectopic Embolization | Gastric Variceal PressureChina
Clinical Trials on Endoscopic ultrasound-guided fine-needle biopsy
-
University of BolognaCompletedPancreatic Adenocarcinoma | Pancreas Cancer | Pancreas MetastasesItaly
-
National Taiwan University HospitalCompleted
-
Texas Tech University Health Sciences Center, El...TerminatedSolid TumorUnited States
-
Azienda Ospedaliera Universitaria Integrata VeronaCompletedEndoscopic Ultrasound | Solid Pancreatic NeoplasmsItaly
-
Asian Institute of Gastroenterology, IndiaNot yet recruitingCholangiocarcinoma PatientsIndia
-
Assiut UniversityUnknown
-
Institutul Regional de Gastroenterologie & Hepatologie...Recruiting
-
National Taiwan University HospitalRecruiting
-
Chungnam National UniversityCompleted
-
University of Sao Paulo General HospitalBoston Scientific Corporation; Medi - GlobeCompletedPancreatic NeoplasmBrazil